33 related articles for article (PubMed ID: 38676365)
1. The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1.
Ning F; Du L; Li J; Wu T; Zhou J; Chen Z; Hu X; Zhang Y; Luan X; Xin H; Yuan C; Zhang X
Life Sci; 2024 Jul; 348():122674. PubMed ID: 38692507
[TBL] [Abstract][Full Text] [Related]
2. MAL2 reprograms lipid metabolism in intrahepatic cholangiocarcinoma via EGFR/SREBP-1 pathway based on single-cell RNA sequencing.
Huang T; Cao H; Liu C; Sun X; Dai S; Liu L; Wang Y; Guo C; Wang X; Gao Y; Tang W; Xia Y
Cell Death Dis; 2024 Jun; 15(6):411. PubMed ID: 38866777
[TBL] [Abstract][Full Text] [Related]
3. RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/β-catenin Signaling Pathway.
Yang Y; Yuan Y; Xia B
Curr Stem Cell Res Ther; 2024; 19(7):1021-1028. PubMed ID: 37861049
[TBL] [Abstract][Full Text] [Related]
4. Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma.
Xiong F; Wang D; Xiong W; Wang X; Huang WH; Wu GH; Liu WZ; Wang Q; Chen JS; Kuai YY; Wang B; Chen YJ
J Exp Clin Cancer Res; 2024 May; 43(1):152. PubMed ID: 38812060
[TBL] [Abstract][Full Text] [Related]
5. GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer.
Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
Mol Biol Rep; 2024 May; 51(1):691. PubMed ID: 38796671
[TBL] [Abstract][Full Text] [Related]
6. FATP5 Is Indispensable for the Growth of Intrahepatic Cholangiocarcinoma.
Shihadih D; Wang X; Zushin PH; Khodakivskyi P; Park HM; Tso E; Shiblak J; Misic A; Louie SM; Ward C; Hellerstein M; Nomura DK; Goun E; Urigo F; Calvisi DF; Chen X; Stahl A
Mol Cancer Res; 2024 Jun; 22(6):585-595. PubMed ID: 38358323
[TBL] [Abstract][Full Text] [Related]
7. Modulating PCGF4/BMI1 Stability Is an Efficient Metastasis-Regulatory Strategy Used by Distinct Subtypes of Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma.
Hu J; Xu H; Ma X; Bai M; Zhou Y; Miao R; Wang F; Li X; Cheng B
Am J Pathol; 2024 Jul; 194(7):1388-1404. PubMed ID: 38670529
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism.
Duan Y; Deng M; Liu B; Meng X; Liao J; Qiu Y; Wu Z; Lin J; Dong Y; Duan Y; Sun Y
Biomaterials; 2024 Sep; 309():122609. PubMed ID: 38754290
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota regulates the ALK5/NOX1 axis by altering glutamine metabolism to inhibit ferroptosis of intrahepatic cholangiocarcinoma cells.
Zhang Q; Zhou J; Zhai D; Jiang Q; Yang M; Zhou M
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167152. PubMed ID: 38582012
[TBL] [Abstract][Full Text] [Related]
10. FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma.
Zhen Y; Liu K; Shi L; Shah S; Xu Q; Ellis H; Balasooriya ER; Kreuzer J; Morris R; Baldwin AS; Juric D; Haas W; Bardeesy N
Nat Commun; 2024 May; 15(1):3805. PubMed ID: 38714664
[TBL] [Abstract][Full Text] [Related]
11. PC4 promotes bladder cancer progression and stemness by directly interacting with Sp1 to transcriptionally activate the Wnt5a/β-catenin pathway.
Yan B; Luo P; Qiu H; Wang J; Xiong Q; Hu W; Wang F; Liu G; Zhi Y; Fang Q; Shi C; Li W
Pathol Res Pract; 2024 Jul; 259():155369. PubMed ID: 38820928
[TBL] [Abstract][Full Text] [Related]
12. SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment.
Czekay RP; Higgins CE; Aydin HB; Samarakoon R; Subasi NB; Higgins SP; Lee H; Higgins PJ
Cells; 2024 May; 13(10):. PubMed ID: 38786020
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of Endogenous Peptide PDYBX1 and Precursor Protein YBX1 in Hirschsprung's Disease.
Sun Q; Zhi Z; Wang C; Du C; Tang J; Li H; Tang W
Neurosci Bull; 2024 Jun; 40(6):695-706. PubMed ID: 37779176
[TBL] [Abstract][Full Text] [Related]
14. YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modification.
Meng H; Miao H; Zhang Y; Chen T; Yuan L; Wan Y; Jiang Y; Zhang L; Cheng W
Cancer Lett; 2024 Jun; ():217064. PubMed ID: 38880223
[TBL] [Abstract][Full Text] [Related]
15. Single-cell analysis defines LGALS1 + fibroblasts that promote proliferation and migration of intrahepatic cholangiocarcinoma.
Cao Q; Yang J; Jiang L; Yang Z; Fan Z; Chen S; Zhu S; Yin L; Wang H; Wen W
J Mol Cell Biol; 2024 Jun; ():. PubMed ID: 38862197
[TBL] [Abstract][Full Text] [Related]
16. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β-catenin axis.
Shi X; Hu Z; Bai S; Zong C; Xue H; Li Y; Li F; Chen L; Xuan J; Xia Y; Wei L; Shen F; Wang K
J Gene Med; 2024 May; 26(5):e3689. PubMed ID: 38676365
[TBL] [Abstract][Full Text] [Related]
17. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway.
Zhang H; Dong X; Ding X; Liu G; Yang F; Song Q; Sun H; Chen G; Li S; Li Y; Wang M; Guo T; Zhang Z; Li B; Yang L
J Transl Med; 2023 Dec; 21(1):900. PubMed ID: 38082327
[TBL] [Abstract][Full Text] [Related]
18. YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.
Huang CS; Zhu YQ; Xu QC; Chen S; Huang Y; Zhao G; Ni X; Liu B; Zhao W; Yin XY
Clin Transl Med; 2022 Jun; 12(6):e848. PubMed ID: 35696608
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription.
Chen Q; Wang H; Li Z; Li F; Liang L; Zou Y; Shen H; Li J; Xia Y; Cheng Z; Yang T; Wang K; Shen F
J Hepatol; 2022 Jan; 76(1):135-147. PubMed ID: 34509526
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
